Enfusion, Inc. (ENFN)
NYSE: ENFN · IEX Real-Time Price · USD
9.25
+0.02 (0.22%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Enfusion Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
8181,2371,1032,367--
Market Cap Growth
-12.12%-53.41%---
Enterprise Value
7981,2161,0472,3038522
PE Ratio
132.14205.24-144.10-14.95--
PS Ratio
4.697.097.3421.19--
PB Ratio
15.2423.0416.9742.81--
P/FCF Ratio
51.2377.46177.17-284.13--
P/OCF Ratio
31.9048.2477.91-7444.52--
EV/Sales Ratio
4.576.976.9720.621.060.37
EV/EBITDA Ratio
33.9751.80222.75-15.4410.021.45
EV/EBIT Ratio
120.58183.88-149.77-15.0413.751.57
EV/FCF Ratio
49.9776.20168.25-276.40-24.872.76
Debt / Equity Ratio
0.290.290.11--0.42-0.23
Debt / EBITDA Ratio
0.660.661.49-11.671.84
Debt / FCF Ratio
0.970.971.12--28.963.51
Quick Ratio
3.143.145.0910.192.451.84
Current Ratio
3.443.445.5711.062.722.00
Asset Turnover
1.641.641.321.542.55-
Interest Coverage
----33.343.7019.15
Return on Equity (ROE)
11.10%11.10%-12.70%177.60%-2.30%-
Return on Assets (ROA)
5.70%5.70%-6.70%-218.10%13.00%-
Return on Capital (ROIC)
12.62%12.62%-16.62%-498.92%-4.07%-14.80%
Earnings Yield
0.74%0.49%-0.69%-6.69%--
FCF Yield
1.95%1.29%0.56%-0.35%--
Buyback Yield / Dilution
-51.57%-51.57%-2.83%26.54%--
Total Shareholder Return
-51.57%-51.57%-2.83%26.54%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).